The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma.
Szymon ZmorzyńskiSylwia Popek-MarciniecWojciech StykM Wojcierowska-LitwinI Korszeń-PileckaAneta Szudy-SzczyrekSylwia ChocholskaMarek HusAgata Anna FilipPublished in: BioMed research international (2020)
The presented results suggest a possible impact of PSMA6 CG+GG genotypes on the MM outcome and the association of the NOD2/CARD15 variant with bortezomib in vitro sensitivity.